Category
Baricitinib
CAS Number
1627504-41-9
Molecular Formula
C₁₉H₂₁N₇O₂
Molecular Weight
379.42 g/mol
Synonym

Tert-Butyl 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-(cyanomethyl)azetidine-1-carboxylate ; Baricitinib Impurity 7 ; 1,1-Dimethylethyl 3-(cyanomethyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-1-azetidinecarboxylate

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Baricitinib Impurity 7 is a process- or degradation-related impurity that can form during the synthesis or storage of Baricitinib. It is structurally related to the parent drug and is monitored under pharmaceutical guidelines to ensure its concentration remains within safe limits, maintaining the drug’s purity, stability, and safety.